FP
NVO

FFG Partners’s Novo Nordisk NVO Stock Holding History

FFG Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Sell
25,719
-41,782
-62% -$1.8M 0.35% 33
2026
Q1 		$2.48M Buy
+67,501
New +$3.2M 0.98% 22
2024
Q3 		– Sell
-83,076
Closed -$11.9M – 32
2024
Q2 		$11.9M Sell
83,076
-20,458
-20% -$2.71M 4.67% 9
2024
Q1 		$13.3M Buy
103,534
+276
+0.3% +$32.9K 5.51% 6
2023
Q4 		$10.7M Buy
+103,258
New +$10.2M 5.7% 8

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

FFG Partners's NVO Position: Q2 2026 in Review

FFG Partners reduced its Novo Nordisk (NVO) stake by 62% in Q2 2026, selling an estimated $1.8M and leaving 25,719 shares worth $1.23M. The position accounts for 0.35% of the portfolio, ranked #33.

FFG Partners first reported a position in NVO in Q4 2023 and has held it in 5 quarters since. The position peaked at $13.3M in Q1 2024. 1,346 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • FFG Partners held 25,719 shares of Novo Nordisk worth $1.23M as of Q2 2026.
  • FFG Partners sold 41,782 Novo Nordisk shares in Q2 2026, an estimated $1.8M.
  • Novo Nordisk made up 0.35% of FFG Partners's portfolio in Q2 2026, its #33 holding.
  • FFG Partners first reported a position in Novo Nordisk in Q4 2023 and has held it in 5 quarters since.
  • FFG Partners's Novo Nordisk position peaked at $13.3M in Q1 2024.
  • 1,346 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on FFG Partners's 13F filing for Q2 2026, filed 9 Jul 2026.